Lantronix Launches Advanced Wireless Embedded IoT Gateways
-- Compact xPico® 200 Gateways Deliver Versatile Connectivity and Intelligent Networking --
IRVINE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Lantronix, Inc. (NASDAQ:LTRX), a global provider of secure data access and management solutions for the industrial Internet of Things (IoT), today announced the launch of its xPico® 200 embedded IoT gateways. Measuring less than the size of a postage stamp, the compact xPico 200 embedded IoT gateways deliver robust Ethernet, Wi-Fi and Bluetooth connectivity, enterprise-grade security, and integrated manageability features that are ideal for industrial IoT applications.
A photo accompanying this announcement is available at
"Today's advanced IoT applications require more than just simple connectivity," stated Shahram Mehraban, Lantronix vice president of marketing. "With the commercial launch of our xPico 200 product family, Lantronix is providing a robust compact solution that combines best-in-class wired and wireless connectivity, industrial grade design and intelligent networking that enables resource-constrained product development teams to reduce total cost of ownership and time to market for their industrial IoT solutions."
"With its state-of-the-art fast roaming capabilities and integrated manageability, the xPico 200 embedded gateways deliver reliable functionality and performance that will enable us to efficiently develop very cost competitive connected products," said Paul Blashewski, president of Prescient Wireless.
Combining the Lantronix intelligent networking communications engine with Cypress Semiconductor's industry-leading wireless SoC, the xPico 200 gateways deliver best-in-class managed industrial Wi-Fi connectivity that enables industrial OEMs to simplify and accelerate development of their smart connected solutions. Currently, the xPico 200 gateways are being designed into industrial, medical, retail, smart building and transportation verticals.
"Lantronix has developed an industry-leading secure embedded solution that enables OEMs to utilize the Cypress CYW43907 802.11n Wi-Fi MCU to provide network reliability and flexibility to do more," said Andrew Hunter, senior director of marketing at Cypress Semiconductor. "The xPico 200 series represents another milestone in our collaboration with Lantronix and addresses the growing need for industrial IoT solutions that deliver robust connectivity, processing capabilities and manageability."
The xPico 200 product family features include:
Highly integrated industrial grade Wi-Fi and versatile connectivity
° Seamlessly integrated Wi-Fi, Ethernet and Bluetooth (BT and BLE) connectivity - no need to write complex drivers
° Dual-band 802.11a/b/g/n Wi-Fi delivers higher performance and reliability, minimizing interference
° Industrial grade design supporting long life and reliable operation in extreme environments
° Lantronix concurrent Soft AP + Client that provides device support and access without disrupting machine field operations
Robust data access and management
° Intelligent networking and automatic connection management
° Field-tested TruPort® Serial and TruPort® Socket enable out-of-the-box connectivity locally and over the Internet for hundreds of serial machine protocols
° Built-in network communications engine simplifies embedded application development
° Pre-integrated with Lantronix MACH10(TM) IoT platform, including MACH10 Global Device Manager
Built-in comprehensive device security services
° Enterprise-grade TruPort® Security ensure security of both data-at-rest and data-in-motion
° Secure connectivity to WPA2-Enterprise Wi-Fi networks
° Secure boot and secure FOTA (firmware over the air) features allow only authorized software to run on the gateway
The xPico 240 is available through the worldwide network of authorized Lantronix distributors and resellers. xPico 250 evaluation kits will be available this month with product availability in early 2018. For more information about the xPico 200 product family, go to www.lantronix.com/xpico-200 or contact a local Lantronix sales office.
Lantronix, Inc. is a global provider of secure data access and management solutions for Internet of Things (IoT) assets. Our mission is to be the leading supplier of IoT solutions that enable companies to dramatically simplify the creation, deployment, and management of IoT projects while providing secure access to data for applications and people.
With more than two decades of experience in creating robust machine to machine (M2M) technologies, Lantronix is an innovator in enabling our customers to build new business models and realize the possibilities of the Internet of Things. Our connectivity solutions are deployed inside millions of machines serving a wide range of industries, including industrial, medical, security, transportation, retail, financial, environmental and government.
Lantronix is headquartered in Irvine, California. For more information, visit www.lantronix.com.
Learn more at the Lantronix blog, www.lantronix.com/blog, featuring industry discussion and updates. To follow Lantronix on Twitter, please visit www.twitter.com/Lantronix. View our video library on YouTube at www.youtube.com/user/LantronixInc or connect with us on LinkedIn at www.linkedin.com/company/lantronix.
Americas +1 (800) 422-7055 (US and Canada) or +1 949-453-3990
Europe, Middle East and Africa +31 (0)76 52 36 744
Asia Pacific + 852 3428-2338
China + 86 21-6237-8868
Japan +81 (0) 50-1354-6201
India +91 994-551-2488
© 2017 Lantronix, Inc. All rights reserved. Lantronix, TruPort and xPico are registered trademarks, and MACH10 is a trademark, of Lantronix Inc. Wi-Fi is a registered trademark of Wi-Fi Alliance. The Bluetooth word mark and Bluetooth Smart Ready are registered trademarks owned by the Bluetooth SIG, Inc. Other trademarks and trade names are those of their respective owners.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lantronix Inc. via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
New Elemica Trace Solution Delivers Shipment Risk Analysis for Digital Transformation19.3.2018 13:09 | Pressemelding
Real-Time Information Matched with GPS Locations Provides Accurate Delivery Information WAYNE, Pa., March 19, 2018 (GLOBE NEWSWIRE) -- Elemica, the leading Digital Supply Network for process manufacturing industries, introduces Elemica Trace, a solution that provides real-time shipment and risk visibility to customer service, transport planners, and supply chain managers, allowing them to monitor and proactively manage the movement of products to customers and inbound to manufacturing centers. "Shipment disruptions occur and teams can spend hours manually tracking down what is happening. What's worse, sometimes your customer complaint is the first indication you have of a late shipment," said Rich Katz, CTO of Elemica. "Trace eliminates the time and stress of tracking shipments and enables your teams to increase the positive interactions with your customers." Elemica Trace uses shipment data, carrier signals, a geo-location interface, and predictive algorithms to identify shipments in
Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial19.3.2018 12:00 | Pressemelding
The BETonMACE trial has now surpassed 2,400 enrolled patients and topline data is expected around the end of 2018 CALGARY, Alberta, March 19, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has successfully surpassed the planned enrollment target of over 2,400 patients in the ongoing Phase 3 BETonMACE trial. The trial's first patient was enrolled on November 11th, 2015. The goal of the trial is to confirm the effect of Resverlogix' lead drug, apabetalone, in Cardiovascular Disease (CVD) patients with type 2 Diabetes Mellitus (DM) and low high-density lipoproteins (HDL). The primary endpoint of the BETonMACE trial is designed to establish a relative risk reduction (RRR) of Major Adverse Cardiac Events (MACE), narrowly defined as a single composite endpoint of cardiovascular death, non-fatal myocardial infarction (MI) and stroke. Secondary pre-specified endpoints in the trial will also examine renal function and MACE in patien
SolarWinds Places Highest on the Ability to Execute Axis in 2018 Gartner Magic Quadrant for Network Performance Monitoring and Diagnostics19.3.2018 11:30 | Pressemelding
AUSTIN, Texas, March 19, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, placed highest on the ability to execute axis in the 2018 Gartner Magic Quadrant for Network Performance Monitoring and Diagnostics1. This Gartner report evaluated 22 suppliers of Network Performance Monitoring and Diagnostics products. The firm's evaluation criteria for ability to execute included the following: product or service, overall viability, sales execution and pricing, market responsiveness and record, marketing execution, customer experience, and operations. Of all the vendors evaluated in the report, SolarWinds placed highest on the ability to execute axis. "For three years in a row, Gartner has positioned us as highest on the ability to execute axis in the Magic Quadrant for Network Performance Monitoring and Diagnostics. In our view, this result confirms our commitment to helping our customers manage their network operations with a powerful
Record High Number of Toll Transactions Cleared in Ireland in 201719.3.2018 10:51 | Pressemelding
ISSY LES MOULINEAUX, France, March 19, 2018 (GLOBE NEWSWIRE) -- The number of transactions processed through emovis's toll interoperability cloud-based hub in Ireland has reached a record high with over 50 million transactions cleared in 2017. Thanks to its toll interoperability solution, emovis is contributing to the improved mobility of millions of Irish drivers, by allowing them to travel seamlessly with just one toll tag across the whole country. As of January 2018, over 650,000 toll transponders are in use. With this new success, emovis demonstrates its leadership in designing and operating innovative mobility solutions that offer the best levels of service for road users in Ireland and throughout the world. About eToll.ie emovis was awarded the contract for managing Ireland's toll interoperability hub by the National Roads Authority (now Transport Infrastructure Ireland) in June 2013 following a competitive tender. As part of this contract, emovis designed, developed and is curre
Phenom People Set to Attend UNLEASH London19.3.2018 09:00 | Pressemelding
Candidate Experience Software Pioneer Attends UK Conference HORSHAM, Pa., March 19, 2018 (GLOBE NEWSWIRE) -- Phenom People, the leader in Talent Relationship Marketing (TRM), announced today that it will attend UNLEASH Conference & Expo on March 20-21 at the ExCel London. "We are no stranger to UNLEASH's strong turnout of highly passionate and forward-thinking individuals who are ready for the next big thing in technology. The inspiration and exchange of new ideas from the world's greatest thought leaders UNLEASH draws in every year, is what we look forward to the most," said Mahe Bayireddi CEO at Phenom People. "Our presence at this year's UNLEASH is vitally important as we continue to emerge as a global TRM leader with a growing list of European clients." UNLEASH, formerly HR Tech World, is held around the globe and was created to enhance the Future of Work by marrying technology with efficient business practices. UNLEASH London's speaker line-up consists of many big-league names inc
Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights16.3.2018 22:32 | Pressemelding
Investor Conference Call on Tuesday, March 27th at 10:00 am ET NEW YORK and CLEVELAND, March 16, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced financial results for the fourth quarter. The Company will host a call to update investors on recent clinical developments and year-end financial results on Tuesday, March 27th at 10:00 am (Eastern). Interested parties are invited to participate in the call by dialing 877-407-9210 (toll free domestic) or 201-689-8049 (International). "The past year was marked by several defining events in the company's history, having advanced our two lead clinical programs, EB-101 in Epidermolysis Bullosa and ABO-102 in MPS IIIA, and initiated our third clinical program, ABO-101 in MPS IIIB. The strong safety and biopotency data observed in our three active clinical trials and the s
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom